Tips and Tricks in Imaging Your Patients With Valvular Heart Disease – Aortic Stenosis, Mitral Regurgitation and Tricuspid Regurgitation

Dr Martin Swaans is cardiologist at St Antonius Hospital Nieuwegein in the Netherlands. Dr Swaans specialises in cardiac imaging, particularly in electrophysiology and interventional procedures. He is a frequent speaker at conferences around the globe and a world authority for interventional imaging. Dr Swaans is heavily involved in the development of cutting edge imaging technologies.

Jose L Zamorano is Professor of Medicine at the University Alcala de Henares, Madrid, and the Chief of Cardiology at the University Hospital Ramón y Cajal.

Prof Zamorano’s has a broad range of research interests including heart failure, ischaemic heart disease, cardiovascular risk factors and cardiovascular imaging modalities. Within these fields, Prof Zamorano he is widely published with over 500 articles and twenty books including the European Textbook of Cardiovascular Imaging. 

Rebecca T Hahn is Director of Interventional Echocardiography at NewYork-Presbyterian/ Columbia University Medical Center, US. She also serves as Professor of Clinical Medicine at Columbia College of Physicians and Surgeons. Dr Hahn completed her medical training at University of Washington School of Medicine, and her residency and fellowship at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr Hahn is board certified in cardiovascular disease, internal medicine and echocardiography.

Personal History

In 1970, Professor Lancellotti was born in Charleroi, Belgium to parents of Neapolitan origin.^{7, 8} He studied chemistry at the University of Labour Paul Pastur and graduated as a technician in 1988.⁷ It was his fascination with the heart and its physiology that drew him to cardiology and he has “always found that the heart was a noble organ.”⁹

Alongside Professor Gach and Dr Robinet, he implanted the first Micra™ (the world's smallest pacemaker) in Wallonia in 2017 and it placed the CHU de Liège/University Hospital of Liège among the centres of European leaders in cardiology.⁷

Philippe Pibarot is Full Professor at the Department of Medicine of Laval University, Canada. He also serves as Director of the Research Group in Valvular Heart Diseases at the Quebec Heart and Lung Institute. He received his doctorate from the University Claude Bernard, France, and his PhD in biomedical sciences from the University of Montreal, Canada. Dr Pibarot has been the recipient of numerous awards including the Annual Achievement Award of the Canadian Society of Echocardiography, and the Research Achievement Award of the Canadian Cardiovascular Society. His key interests include valvular heart diseases, cardiovascular surgery, heart valve diseases, and pulmonary hypertension.